SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N HSQC1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 600
22D 1H-13C HSQC aliphatic1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 600
32D 1H-13C HSQC aromatic1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 600
43D HNCA1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 600
53D HNCACB1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 600
63D CBCA(CO)NH1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 600
83D 15N-edited [1H,1H]-NOESY1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 800
73D 13Cali-edited [1H,1H]-NOESY1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 800
93D 13Caro-edited [1H,1H]-NOESY1 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 20 mM sodium phosphate, 50 mM sodium chloride, pH 5.5 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm298Bruker AVANCE III 800
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE III600
2BrukerAVANCE III800
NMR Refinement
MethodDetailsSoftware
molecular dynamicsthe structures are based on a total of 3098 NOE-derived restraints, 208 dihedral angle restraints, 60 distance restraints from hydrogen bondsCYANA
Constrained energy minimizationOPALp
NMR Ensemble Information
Conformer Selection Criteriastructures with acceptable covalent geometry
Conformers Calculated Total Number40
Conformers Submitted Total Number10
Representative Model1 (closest to the average)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBruker Biospin
2processingTopSpinBruker Biospin
3chemical shift assignmentCARAKeller and Wuthrich
4peak pickingCARAKeller and Wuthrich
5refinementCYANAGuntert, Mumenthaler and Wuthrich
6structure calculationUNIO10-ATNOS/CANID2.0.2Dr. Torsten Herrmann
7refinementOPALpKoradi et al, 2000
8refinementPrimePrime, Schrodinger, LLC, New York, NY, 2018
9structure calculationCYANAGuntert, Mumenthaler and Wuthrich